Impact of COVID-19 on cervical cancer screening: A cohort study
The COVID-19 pandemic is associated with increased abnormal Pap smear rates and a substantial reduction of total screened volume. The study highlights the value of proactive measures-such as implementing mobile vehicle screenings for the high risk or underserved population-for maintaining essential health-care services and screening programs during global health emergencies to minimize the consequences of disruptions in cancer screenings.
Authors
- Jin‐Yin Chang
- Hon‐Ping Ma (ORCID: https://orcid.org/0000-0001-7568-1451)
- Chen Shui
- Ka‐Wai Tam (ORCID: https://orcid.org/0000-0002-1994-834X)
- Wan‐Yun Chou (ORCID: https://orcid.org/0000-0001-7799-9391)
- Hui Wang (ORCID: https://orcid.org/0000-0001-5109-8691)
- Chih‐Ming Ho (ORCID: https://orcid.org/0000-0003-0634-0439)
- Ya-Lun Tsai (ORCID: https://orcid.org/0009-0004-1357-481X)
- Ming‐Song Tsai
Institutions
- Fu Jen Catholic University (TW)
- Taipei Medical University Hospital (TW)
- Cathay General Hospital (TW)
- Taipei Medical University-Shuang Ho Hospital (TW)
Publication Details
- Journal
- Journal of the Formosan Medical Association
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.jfma.2025.10.029
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 1.05